These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1189 related articles for article (PubMed ID: 17087942)

  • 41. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.
    Sideris M; Papagrigoriadis S
    Anticancer Res; 2014 May; 34(5):2061-8. PubMed ID: 24778007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
    Bae JM; Kim JH; Kang GH
    Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.
    Cai G; Xu Y; Lu H; Shi Y; Lian P; Peng J; Du X; Zhou X; Guan Z; Shi D; Cai S
    Int J Colorectal Dis; 2008 Apr; 23(4):365-73. PubMed ID: 18193434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
    Ogino S; Cantor M; Kawasaki T; Brahmandam M; Kirkner GJ; Weisenberger DJ; Campan M; Laird PW; Loda M; Fuchs CS
    Gut; 2006 Jul; 55(7):1000-6. PubMed ID: 16407376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers.
    Silver A; Sengupta N; Propper D; Wilson P; Hagemann T; Patel A; Parker A; Ghosh A; Feakins R; Dorudi S; Suraweera N
    Int J Cancer; 2012 Mar; 130(5):1082-92. PubMed ID: 21455990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Four molecular subtypes of colorectal cancer and their precursor lesions.
    Kang GH
    Arch Pathol Lab Med; 2011 Jun; 135(6):698-703. PubMed ID: 21631262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.
    Melcher R; Hartmann E; Zopf W; Herterich S; Wilke P; Müller L; Rosler E; Kudlich T; Al-Taie O; Rosenwald A; Katzenberger T; Scholtka B; Seibold S; Rogoll D; Scheppach W; Scheurlen M; Lührs H
    Carcinogenesis; 2011 Apr; 32(4):636-42. PubMed ID: 21297112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.
    Cohen Y; Merhavi-Shoham E; Avraham RB; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Exp Eye Res; 2008 Feb; 86(2):201-6. PubMed ID: 18068703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
    J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
    Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Ogino S; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS
    Int J Cancer; 2008 Jun; 122(12):2767-73. PubMed ID: 18366060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
    Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
    Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of chromosomal imbalances in CIMP-high and CIMP-low/CIMP-0 colorectal cancers.
    Kozlowska J; Karpinski P; Szmida E; Laczmanska I; Misiak B; Ramsey D; Bebenek M; Kielan W; Pesz KA; Sasiadek MM
    Tumour Biol; 2012 Aug; 33(4):1015-9. PubMed ID: 22274926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.
    Samadder NJ; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
    Gastroenterology; 2013 Aug; 145(2):348-56.e1-2. PubMed ID: 23665275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
    Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
    Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
    Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
    Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
    Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.